Lord, Abbett & Co’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,442,956
| Closed | -$24M | – | 575 |
|
|
2023
Q4 | $24M | Sell |
2,442,956
-1,222,921
| -33% | -$12M | 0.08% | 304 |
|
|
2023
Q3 | $30.6M | Sell |
3,665,877
-17,989
| -0.5% | -$150K | 0.11% | 250 |
|
|
2023
Q2 | $49M | Buy |
3,683,866
+251,862
| +7% | +$3.35M | 0.17% | 181 |
|
|
2023
Q1 | $39.7M | Sell |
3,432,004
-780,131
| -19% | -$9.03M | 0.14% | 219 |
|
|
2022
Q4 | $34.5M | Buy |
+4,212,135
| New | +$34.5M | 0.12% | 243 |
|
|
2021
Q2 | – | Sell |
-1,019,453
| Closed | -$34M | – | 687 |
|
|
2021
Q1 | $34M | Sell |
1,019,453
-1,190,872
| -54% | -$39.7M | 0.09% | 333 |
|
|
2020
Q4 | $57.3M | Sell |
2,210,325
-522,875
| -19% | -$13.6M | 0.15% | 220 |
|
|
2020
Q3 | $27M | Buy |
+2,733,200
| New | +$27M | 0.09% | 321 |
|
|
2017
Q4 | – | Sell |
-814,484
| Closed | -$4.28M | – | 893 |
|
|
2017
Q3 | $4.28M | Buy |
814,484
+221,473
| +37% | +$1.16M | 0.01% | 787 |
|
|
2017
Q2 | $2.11M | Sell |
593,011
-294,233
| -33% | -$1.05M | 0.01% | 854 |
|
|
2017
Q1 | $4.59M | Sell |
887,244
-1,806,474
| -67% | -$9.34M | 0.01% | 761 |
|
|
2016
Q4 | $10.2M | Sell |
2,693,718
-3,700,646
| -58% | -$14.1M | 0.03% | 572 |
|
|
2016
Q3 | $57.3M | Buy |
6,394,364
+227,271
| +4% | +$2.04M | 0.17% | 185 |
|
|
2016
Q2 | $43.4M | Buy |
6,167,093
+2,510,152
| +69% | +$17.7M | 0.14% | 233 |
|
|
2016
Q1 | $31.1M | Buy |
3,656,941
+37,682
| +1% | +$320K | 0.1% | 309 |
|
|
2015
Q4 | $47.5M | Buy |
+3,619,259
| New | +$47.5M | 0.14% | 217 |
|
|
2015
Q3 | – | Sell |
-608,985
| Closed | -$3.51M | – | 946 |
|
|
2015
Q2 | $3.51M | Buy |
608,985
+137,832
| +29% | +$794K | 0.01% | 818 |
|
|
2015
Q1 | $2.75M | Buy |
+471,153
| New | +$2.75M | 0.01% | 822 |
|